Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
Page 1 of 1
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
Jon Moulton Fri Feb 11, 2011 10:26 am
Goyenvalle A, Davies KE. Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy. Skeletal Muscle. 2011;1:8 doi:10.1186/2044-5040-1-8
Last edited by Jon Moulton on Fri Feb 11, 2011 10:26 am; edited 1 time in total (Reason for editing : Oops link)
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in duchenne muscular dystrophy
» Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
» Eteplirsen for the treatment of duchenne muscular dystrophy
» Exon-skipping therapy for Duchenne muscular dystrophy
» Exon skipping approach to duchenne muscular dystrophy
» Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
» Eteplirsen for the treatment of duchenne muscular dystrophy
» Exon-skipping therapy for Duchenne muscular dystrophy
» Exon skipping approach to duchenne muscular dystrophy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum